- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 120.2M sh |
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 122.18M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $64.82M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $115.85M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $190.51M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $495.24M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $195.93M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $289.78M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $276.08M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $307.68M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $396.53M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $762.88M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.06B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.12B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 123.14M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $255K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$38.09M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $796.99M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $786.12M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $31.6M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $16.74M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$6.22M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$5.96M |
| Revenue | Q1 2025 · Mar 31, 2024 | $114.1M |